Diagnosing CSU can be difficult for a few main reasons, including the following: CSU is often misdiagnosed because hives are ...

"Medical Journeys" chart a path each step of the way for physicians and patients and provide continual resources and support, ...

About half of people with "chronic spontaneous urticaria," or CSU, the most common type of chronic hives, experience what ...

Learn about the impressive health benefits of jujube, a fruit known for improving sleep, boosting immunity, aiding digestion, ...

Acute urticaria (hives) is a common skin condition that affects up to 20% of people at some point in their lives. It can transition into chronic urticaria for up to 8% of the population. Hives tend to ...

Jasper Therapeutics, Inc.'s Briquilimab shows promise in treating chronic urticaria and asthma, with potential market approval by 2027, offering significant revenue opportunities in large ...

Keywords: Chronic inducible urticaria; cold urticaria, cholinergic urticaria, contact urticaria, delayed pressure urticaria, immunoglobulin E, mast cells, patient-reported outcomes, provocation ...

Novartis is just months away from filing for approval of oral BTK inhibitor remibrutinib as a treatment for chronic spontaneous urticaria – also known as chronic hives – after reporting long ...

1 Department of Dermatology, Southwest Hospital, Army Medical University, Chongqing, China 2 Department of Pathophysiology, Army Medical University, Chongqing, China Introduction: Chronic urticaria ...

but can now point to a win for rilzabrutinib in chronic spontaneous urticaria (CSU). In a phase 2 trial, rilzabrutinib has been shown to rapidly reduce itch severity and significantly improve ...

Celltrion today announced that Health Canada has approved Omlyclo™, a biosimilar referencing Xolair®. Omlyclo™ is approved ...